8/1/2023 0 Comments Norman schwartz bio rad![]() It's most recent major acquisition prior to RainDance was of GnuBio in 2014 for $110 million. Schwartz had hinted in a Q3 earnings call in November that it was scoping out M&A possibilities and something might come to pass in the following three to six months. However, RainDance also reduced its staff by about 10 percent last year and pulled a planned initial public offering citing market conditions. RainDance has also partnered with Pacific Biosciences to co-develop and commercialize solutions for de novo whole-genome assembly. It signed a multi-year supply agreement with Myriad Genetics, for example, which uses 30 in-house RainDance ThunderStorm platforms to set up PCR reactions for target amplification prior to sequencing. RainDance also has several partnerships in the clinical space. "We look forward to expanding our offering to provide life science and clinical diagnostics customers with solutions for a wide range of nucleic acid detection applications," Schwartz said.ĭroplet-based PCR from both Bio-Rad and RainDance has been developed for oncology and liquid biopsy applications, viral load monitoring, as well as copy number variation and mosaicism research.īio-Rad announced last week the launch of a single-cell sequencing system co-developed with Illumina. The RainDance intellectual property portfolio will extend Bio-Rad's reach into next-generation sequencing applications and strengthen its position in the area of droplet digital PCR, Bio-Rad CEO Norman Schwartz said in a statement. The RainDance system partitions samples into some 10 million droplets, which is purportedly 500 times greater than the number generated by the Bio-Rad systems. RainDance's systems include RainDrop Digital PCR, ThunderStorm, and ThunderBolts Next-Generation Sequencing Enrichment. The acquisition is expected to close during the first quarter of 2017. NEW YORK (GenomeWeb) – Bio-Rad Laboratories announced today that it has agreed to acquire rival droplet-based PCR systems manufacturer RainDance Technologies for an undisclosed amount. This article has been updated from a previous version to correct the number of droplets generated by the RainDance digital PCR system. ![]() Advances in Clinical Genomics Profiling.I trust all of you share our vision of a sustainable future. We have a strong record of achievement and contribution to the world we live in, but we can always do more. As a science-based company, we have grown up with respect for our environment, our communities, and the individuals we work shoulder-to-shoulder with every day. ![]() Additionally, we are committed to providing greater transparency with our disclosures and plan to publish our first formal sustainability report based on the GRI framework by mid-2022. Our new sustainability strategy includes six long-term goals that are highlighted on this page. In 2021, Bio-Rad conducted a materiality assessment to identify the highest priority topics for sustainability and to set targets for improvement. Equally important is minimizing our impact on the environment and making a difference in the many communities we serve in meaningful ways.įulfilling these goals is more complex and challenging than ever before as the world around us continues to evolve, placing new demands and greater expectations on companies. Most important to us is ensuring the highest standards of business ethics and integrity throughout our global operation, a responsibility of every employee at Bio-Rad. It is our privilege to be part of the process of helping people live longer, healthier lives, however we realize this aspiration comes with responsibilities to those we serve, the environment, our employees and partners, as well as the many communities in which we work. Since we first began 70 years ago, Bio-Rad has been committed to its vision of providing useful products and solutions that help life science researchers accelerate the discovery process and clinical diagnostics laboratorians obtain faster, more accurate results.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |